AbCellera Biologics Inc. ABCL Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s operating lease liabilities (current)?
- AbCellera Biologics Inc. (ABCL) reported operating lease liabilities (current) of $5.87M in Q1 2026.
- How has AbCellera Biologics Inc.'s operating lease liabilities (current) changed year-over-year?
- AbCellera Biologics Inc.'s operating lease liabilities (current) increased by 26.6% year-over-year, from $4.64M to $5.87M.
- What is the long-term trend for AbCellera Biologics Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s operating lease liabilities (current) has grown at a 53.8% compound annual growth rate (CAGR), from $675K to $5.82M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.